To confirm the immunohistochemistry findings, we randomly chose 20 of these 45 CCRCC tumors for a western blot analysis, significant AIF downregulation was detected in 17 out of 20 cases (Fig. 1C). The gene discussed is AIFM1; the disease is nonpapillary renal cell carcinoma.